Literature DB >> 14634110

Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.

Sabine Middendorp1, Gemma M Dingjan, Alex Maas, Katarina Dahlenborg, Rudolf W Hendriks.   

Abstract

The Tec family member Bruton's tyrosine kinase (Btk) is a cytoplasmic protein tyrosine kinase that transduces signals from the pre-B and B cell receptor (BCR). Btk is involved in pre-B cell maturation by regulating IL-7 responsiveness, cell surface phenotype changes, and the activation of lambda L chain gene rearrangements. In mature B cells, Btk is essential for BCR-mediated proliferation and survival. Upon BCR stimulation, Btk is transphosphorylated at position Y551, which promotes its catalytic activity and subsequently results in autophosphorylation at position Y223 in the Src homology 3 domain. To address the significance of Y223 autophosphorylation and the requirement of enzymatic activity for Btk function in vivo, we generated transgenic mice that express the autophosphorylation site mutant Y223F and the kinase-inactive mutant K430R, respectively. We found that Y223 autophosphorylation was not required for the regulation of IL-7 responsiveness and cell surface phenotype changes in differentiating pre-B cells, or for peripheral B cell differentiation. However, expression of the Y223F-Btk transgene could not fully rescue the reduction of lambda L chain usage in Btk-deficient mice. In contrast, transgenic expression of kinase-inactive K430R-Btk completely reconstituted lambda usage in Btk-deficient mice, but the defective modulation of pre-B cell surface markers, peripheral B cell survival, and BCR-mediated NF-kappaB induction were partially corrected. From these findings, we conclude that: 1) autophosphorylation at position Y223 is not essential for Btk function in vivo, except for regulation of lambda L chain usage, and 2) during B cell development, Btk partially acts as an adapter molecule, independent of its catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634110     DOI: 10.4049/jimmunol.171.11.5988

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.

Authors:  Sebastian Herzog; Bettina Storch; Hassan Jumaa
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas.

Authors:  Shariful Islam; Wenqing Qi; Carla Morales; Laurence Cooke; Catherine Spier; Eric Weterings; Daruka Mahadevan
Journal:  Mol Cancer Ther       Date:  2017-06-14       Impact factor: 6.261

3.  In senescence, age-associated B cells secrete TNFα and inhibit survival of B-cell precursors.

Authors:  Michelle Ratliff; Sarah Alter; Daniela Frasca; Bonnie B Blomberg; Richard L Riley
Journal:  Aging Cell       Date:  2013-04       Impact factor: 9.304

Review 4.  BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.

Authors:  M Spaargaren; M F M de Rooij; A P Kater; E Eldering
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

5.  Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.

Authors:  Rachel H Bonami; Allison M Sullivan; James B Case; Hannah E Steinberg; Kristen L Hoek; Wasif N Khan; Peggy L Kendall
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

6.  Reply.

Authors:  Lindsay E Nyhoff; Leslie J Crofford; Peggy L Kendall
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 7.  Non-kinase targets of protein kinase inhibitors.

Authors:  Lenka Munoz
Journal:  Nat Rev Drug Discov       Date:  2017-03-10       Impact factor: 84.694

8.  Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells.

Authors:  Niklas Feldhahn; Paula Río; Bonaventure Ndikung Bejeng Soh; Stefanie Liedtke; Mieke Sprangers; Florian Klein; Peter Wernet; Hassan Jumaa; Wolf-Karsten Hofmann; Helmut Hanenberg; Janet D Rowley; Markus Müschen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

9.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 10.  Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

Authors:  Maike Buchner; Markus Müschen
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.